Drug
2 Td1414
2 Td1414: highest development phase Phase 2, developed by LEO Pharma. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- LEO Pharma
Trials
| Drug | Phase | Indication |
|---|---|---|
| 2% TD1414 Cream NCT00758862 | Phase 2 | Secondarily Infected Traumatic Lesions (SITL) |
Latest
No recent events.
Follow 2 Td1414 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.